NASDAQ:TRVN

Trevena Stock Predictions

Healthcare > Biotechnology

Buy TRVN

*Your capital is at risk

$0.0010

+0 (+0%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

TRVN Prediction Chart

TRVN Predictions History

Latest community submissions for TRVN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PumpTheseNumbers Pro	Mar 6, 2019	$1.55 -99.83%	$1.48	X	95.30%	0
JS Pro	Mar 5, 2019	$1.57 -99.84%	$1.53	X	97.40%	0
Gp Merchant @Gp.98898	Mar 4, 2019	$1.38 -99.85%	$1.50	X	92.00%	0
PumpTheseNumbers Pro	Mar 4, 2019	$1.39 -99.85%	$1.50	X	92.70%	0
JS Pro	Mar 4, 2019	$1.38 -99.85%	$1.50	X	92.00%	0
PumpTheseNumbers Pro	Feb 27, 2019	$1.47 -99.83%	$1.42	X	96.50%	0
JS Pro	Feb 27, 2019	$1.41 -99.84%	$1.42	V	99.30%	3
Andy.Kirkwood.96939	Feb 19, 2019	$1.72 -99.82%	$1.49	X	84.56%	0
PumpTheseNumbers Pro	Feb 14, 2019	$1.51 -99.84%	$1.55	X	97.40%	0
JS Pro	Feb 14, 2019	$1.42 -99.85%	$1.55	V	91.60%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TRVN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT TREVENA

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abno...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by